United States · FDA National Drug Code directory
TICAGRELOR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76282-550_62c87369-6ec3-4cd5-82c6-a81c752be6ca
- Product NDC
- 76282-550
- Form
- TABLET, FILM COATED
- Composition / generic term
- TICAGRELOR
- Labeler
- Exelan Pharmaceuticals, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250507
- Source listing expiry
- 20261231
Source-listed ingredients
- TICAGRELOR — 90 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (76282-550-01) · 76282-550-01
- 500 TABLET, FILM COATED in 1 BOTTLE (76282-550-05) · 76282-550-05
- 60 TABLET, FILM COATED in 1 BOTTLE (76282-550-60) · 76282-550-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →